Bodal Chemicals disclosed that Ashokkumar Giriraj Bansal acquired 1,75,000 equity shares in the open market on September 11, 2026. The transaction increases his stake to 5.01% of the company’s total voting capital.

The acquisition was made in the open market and involves plain equity shares carrying voting rights. There were no warrants, convertible securities, or encumbrances associated with the purchase.

Shareholding Details

Before the transaction, Ashokkumar Giriraj Bansal held 61,30,000 shares, representing 4.87% of the total share capital. The addition of 1,75,000 shares brings his total holding to 63,05,000 shares.

The target company’s total equity share capital remains unchanged at 1,25,944,065 equity shares of Re. 2/- each, aggregating ₹25,18,88,130.

Regulatory Disclosure

The disclosure was filed under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that Ashokkumar Giriraj Bansal does not belong to the promoter or promoter group of Bodal Chemicals Limited. No persons acting in concert (PAC) were reported alongside the acquirer.

Bodal Chemicals filed its Annual Report for FY26 with stock exchanges on August 31, 2026, ahead of its 40th AGM scheduled for September 25, 2026. Consolidated revenue rose 16.9% YoY to ₹2,053.9 crore while PAT surged 158.5% to ₹47.8 crore.

The filing was made pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The 40th AGM will be held via video conferencing at 12:00 noon. The Board recommended no dividend for FY26, citing prevailing business conditions and the company's Dividend Distribution Policy.

FY26 Financial Performance (Consolidated)

FY26 marked a significant recovery for Bodal Chemicals, with the company crossing the ₹2,000 crore revenue milestone. Growth was driven by improved volumes across segments, better realisations, and recognition of SGST incentive income from the Punjab Industrial Incentive Scheme.

Key financial ratios also improved. Return on equity rose from 1.7% to 4.1%, return on capital employed expanded from 6.8% to 8.9%, and net working capital days declined from 124.9 to 104.8, reflecting tighter operational efficiency. The debt-equity ratio improved from 0.79x to 0.67x.

Segment-Wise Revenue Performance

All three core segments registered YoY revenue growth. Basic Chemicals recorded the sharpest expansion, driven by elevated sulphur prices and progressive ramp-up of the Saykha benzene downstream facility.

The Chlor-Alkali business reported revenue of ₹3,387 mn, remaining broadly in line on a YoY basis as demand gained traction from water treatment and hygiene segments.

Saykha Greenfield Facility and Strategic Expansion

A key strategic milestone during the year was the commissioning and ramp-up of the greenfield facility at Saykha, Gujarat. This facility marks Bodal Chemicals' entry into benzene derivatives — including MCB, PNCB, ONCB, MNCB, and DCB — opening access to pharmaceuticals, agrochemicals, pigments, and polymer markets. The plant is equipped with German Adiabatic Nitration Technology and India's first Continuous Crystallisation system for PNCB, sourced from Switzerland. Total benzene downstream capacity stands at 63,000 MTPA.

The company also permanently decommissioned legacy units at Vatva, with production absorbed by upgraded facilities at Vadodara and Kosi, delivering reduced fixed overheads and improved energy efficiency. During the year, Unit II and Unit III at Vatva were sold to unrelated parties at prevailing market prices.

Subsidiary Performance

Subsidiaries in China and Indonesia were standout performers, recording strong double-digit revenue growth. The Turkish subsidiary, Sener Boya, was impacted by hyperinflationary conditions.

Capital Structure and Debt

As on March 31, 2026, total debt stood at ₹8,001.57 mn, with cash and cash equivalents of ₹74.61 mn, resulting in net debt of ₹7,926.96 mn compared to ₹8,921.73 mn as on March 31, 2025. Working capital loans comprised ₹4,599.90 mn and long-term loans ₹3,401.67 mn. Capital expenditure for the year was ₹356.28 mn. The company's bank facilities aggregating ₹1,127.53 crore carry a long-term rating of IVR A- Stable and short-term rating of IVR A2+ from Infometrics Valuation and Rating Ltd.

AGM Details and Agenda

The 40th AGM is scheduled for Friday, September 25, 2026, via video conferencing at 12:00 noon. Key agenda items include:

• Adoption of financial statements: Audited standalone and consolidated financial statements for FY26
• Director reappointment: Mr. Ankit S. Patel (DIN: 02173231), Executive Director, retires by rotation and offers himself for reappointment; he held 72,61,072 shares (5.77% of paid-up capital) as on March 31, 2026
• Cost auditor remuneration: Ratification of ₹1,80,000 plus GST for M/s. Kiran J. Mehta & Co. for FY27

Remote e-voting via CDSL runs from 9:00 am on September 22, 2026 to 5:00 pm on September 23, 2026. The record date is September 18, 2026 and the register of members remains closed from September 19 to September 25, 2026.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE338D01028/2eb908fd-c5ac-4417-bbe8-cab82a5f0e4d.pdf